BPC-157 Protocol (2 mL Reconstitution = 2.5 mg/mL) Route: Subcutaneous injection, preferably near the site of injury
The association of ROS with neuronal degeneration in PD is further substantiated by modeling the Parkinsonian phenotypes in animals through 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), rotenone, 1,1-dimethyl-4,4-bipyridinium dichloride (paraquat), or 6-hydroxydopamine (6-OHDA), those are known of elevate the oxygen free-radicals in the cell 18
Others supply it pre-mixed at a specific concentration (commonly 10mg/mL or 20mg/mL)
Limitations to Consider: The absorption variability creates uncertainty about whether youre receiving therapeutic doses
I still remember spotting it on the first floor and tossing it into my basket without hesitation